Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease

[1]  J. Kastelein,et al.  Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. , 2015, JAMA.

[2]  A. Ashley-Koch,et al.  Factors associated with survival in a contemporary adult sickle cell disease cohort , 2014, American journal of hematology.

[3]  P. Sebastiani,et al.  Hypoxic Response Contributes to Altered Gene Expression and Precapillary Pulmonary Hypertension in Patients With Sickle Cell Disease , 2014, Circulation.

[4]  M. Gladwin,et al.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia , 2014, British journal of haematology.

[5]  S. Going,et al.  Body composition in children. , 2013, Pediatric exercise science.

[6]  M. Laakso,et al.  Genetic Screening for the Risk of Type 2 Diabetes , 2013, Diabetes Care.

[7]  D. McClain,et al.  Iron and diabetes risk. , 2013, Cell metabolism.

[8]  Christopher D. Brown,et al.  Integrative Modeling of eQTLs and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of eQTLs , 2012, PLoS genetics.

[9]  S. Hunt,et al.  Adipocyte iron regulates adiponectin and insulin sensitivity. , 2012, The Journal of clinical investigation.

[10]  J. Prchal,et al.  Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism , 2012, Journal of Molecular Medicine.

[11]  Paola Sebastiani,et al.  Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. , 2012, Blood.

[12]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[13]  Greg Gibson,et al.  Rare and common variants: twenty arguments , 2012, Nature Reviews Genetics.

[14]  Simon C. Potter,et al.  A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans , 2012, PLoS ONE.

[15]  M. Gladwin,et al.  Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. , 2011, Blood.

[16]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[17]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[18]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[19]  B. Browning,et al.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.

[20]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[21]  J. Morrow,et al.  Energy Expenditure, Inflammation, and Oxidative Stress in Steady-State Adolescents With Sickle Cell Anemia , 2007, Pediatric Research.

[22]  M. Permutt,et al.  Genetic epidemiology of diabetes. , 2005, The Journal of clinical investigation.

[23]  D. Altshuler,et al.  The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. , 2003, Annual review of genomics and human genetics.

[24]  A. Scheen,et al.  PATHOPHYSIOLOGY OF TYPE 2 DIABETES , 2003, Acta clinica Belgica.

[25]  De-Pei Liu,et al.  Regulation of human apolipoprotein B gene expression at multiple levels. , 2003, Experimental cell research.

[26]  B. Zemel,et al.  Body composition in children with sickle cell disease. , 2002, The American journal of clinical nutrition.

[27]  J. Sparks,et al.  B48 is preferentially translated over B100 in cells with increased endogenous apo B mRNA. , 2000, Biochemical and biophysical research communications.

[28]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[29]  G. Rodgers,et al.  Mortality in sickle cell disease. , 1994 .

[30]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[31]  D. Firth.  Bias reduction of maximum likelihood estimates , 1993 .

[32]  Graham R Serjeant,et al.  Sickle-cell disease , 1984, The Lancet.

[33]  A. Kitabchi,et al.  The prevalence of diabetes mellitus in sickle cell hemoglobinopathies. , 1979, The Journal of clinical endocrinology and metabolism.

[34]  L. Pauling,et al.  Sickle cell anemia a molecular disease. , 1949, Science.

[35]  Wei Zhang,et al.  Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing. , 2014, Blood cells, molecules & diseases.

[36]  J. Prchal,et al.  Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism , 2012, Journal of Molecular Medicine.

[37]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[38]  M. Goran,et al.  Total and resting energy expenditure in children with sickle cell disease. , 2000, The Journal of pediatrics.